Waterloo Capital’s Alpha Tau Medical DRTS Stock Holding History

Waterloo Capital’s Portfolio DRTS Stock Details DRTS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$145K	Buy	+11,500	New	+$104K	0.01%	555

Other funds holding DRTS

Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return

Levin Capital Strategies New York $1.49B AUM 30.44% 1-Year Est. Return

Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Woodstock Corp Boston, Massachusetts $1.2B AUM 26.37% 1-Year Est. Return

Financial Guidance Group Palm Harbor, Florida $267M AUM 19.62% 1-Year Est. Return

Cambridge Investment Research Advisors

Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return

Everhart Financial Group Dublin, Ohio $1.56B AUM 34.29% 1-Year Est. Return

Opal Wealth Advisors Jericho, New York $463M AUM 20.47% 1-Year Est. Return

Tower View Wealth Management Shorewood, Wisconsin $227M AUM 41.04% 1-Year Est. Return

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

Waterloo Capital's DRTS Position: Q2 2026 in Review

Waterloo Capital opened a new position in Alpha Tau Medical (DRTS) in Q2 2026: 11,500 shares worth $145K. The stake represents 0.01% of the portfolio and ranks #555 among its holdings.

15 funds tracked by Wall St. Rank hold DRTS as of Q2 2026.

Waterloo Capital held 11,500 shares of Alpha Tau Medical worth $145K as of Q2 2026.
Alpha Tau Medical was a new Waterloo Capital position in Q2 2026.
Alpha Tau Medical made up 0.01% of Waterloo Capital's portfolio in Q2 2026, its #555 holding.
15 funds tracked by Wall St. Rank held Alpha Tau Medical as of Q2 2026.

Based on Waterloo Capital's 13F filing for Q2 2026, filed 29 Jul 2026.